APA   Click to copy
Momotow, J., Goergen, H., Behringer, K., Bröckelmann, P. J., Borchmann, S., v. Tresckow, B., … Sasse, S. (2019). Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma - Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center. HemaSphere, 3(5).

Chicago/Turabian   Click to copy
Momotow, Jesko, Helen Goergen, Karolin Behringer, Paul J. Bröckelmann, Sven Borchmann, Bastian v. Tresckow, Carsten Kobe, Andreas Engert, and Stephanie Sasse. “Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma - Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center.” HemaSphere 3, no. 5 (August 27, 2019).

MLA   Click to copy
Momotow, Jesko, et al. “Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma - Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center.” HemaSphere, vol. 3, no. 5, Aug. 2019.

@article{jesko2019a,
  title = {Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma - Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center.},
  year = {2019},
  month = aug,
  day = {27},
  issue = {5},
  journal = {HemaSphere},
  volume = {3},
  author = {Momotow, Jesko and Goergen, Helen and Behringer, Karolin and Bröckelmann, Paul J. and Borchmann, Sven and v. Tresckow, Bastian and Kobe, Carsten and Engert, Andreas and Sasse, Stephanie},
  month_numeric = {8}
}